Skip to main content
Clinical Trials/NCT00319579
NCT00319579
Completed
Not Applicable

The Long Term Medical and Psychological Implications of Becoming a Living Kidney Donor: A Prospective Pilot Study

Amit Garg15 sites in 3 countries330 target enrollmentJanuary 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Living Kidney Donors
Sponsor
Amit Garg
Enrollment
330
Locations
15
Primary Endpoint
Hypertension in living kidney donors
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Kidney transplantation, a 'miracle' of modern medicine, is the preferred treatment option for End Stage Renal Disease compared to dialysis, patients who receive kidneys have a 70% reduction in risk of death, a dramatically improved quality of life and cost the health care system considerably less. As a result there are over 3000 Canadians, and 57,000 Americans on the waiting list for a kidney. To meet the shortage in cadaveric kidneys, rates of living kidney donation have nearly doubled over the last 10 years, and will continue to rise with growing demand.

Yet despite its advantages for the recipient, living kidney donation remains a complex ethical, moral and medical issue. The premise for accepting living donors is that the "minimal" risk of short and long-term medical harm realized by the donor is outweighed by the definite advantages to the recipient and potential psychosocial benefits of the altruistic gift to the donor. The only benefit for the living donor is psychological - donors experience increased self-esteem, feelings of well-being and improved health related quality of life with their altruistic act of assuming medical risk to help another. The short-term consequences of living donation are well established. On the other hand the long-term implications of living kidney donation are far less certain. This study will look at the long term implications of living kidney donation.

Registry
clinicaltrials.gov
Start Date
January 2005
End Date
August 2009
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Amit Garg
Responsible Party
Sponsor Investigator
Principal Investigator

Amit Garg

MD, MA, FRCPC, FACP, PhD

Lawson Health Research Institute

Eligibility Criteria

Inclusion Criteria

  • Age greater than 18 years old
  • A predicted Cockcroft-Gault creatinine clearance \> 80 mL/min
  • Average sBP \< 140 and dBP \< 90 based on 3 readings
  • A spot urine protein to creatinine ratio \< 15 mg/mmol

Exclusion Criteria

  • A medical condition (such as cardiovascular disease, pulmonary disease, active cancer) or psychological condition (such as major affective disorder, personality disorder, a history of chemical dependence) which the local transplant centre deems unfit for donation. Blood group and immunological incompatibility (such as positive cross-match, poor HLA matches) are not reasons for exclusion
  • Evidence of a financial incentive for donation
  • A contraindication to general anaesthesia or surgery
  • A past medical history of hypertension
  • Use of antihypertensive class medications for any reason.(ACE-Is, ARBs, diuretics, beta-blockers, calcium channel blockers)
  • A past history of permanent proteinuria
  • The eligible non-donor is planning to donate their kidney within the next year
  • Unable to give informed consent
  • Unwilling to participate in the follow-up assessments at one, two, three, four and five years, or unwilling or unable to conduct home blood pressure or laboratory measurements
  • The living donor or eligible non-donor is currently pregnant

Outcomes

Primary Outcomes

Hypertension in living kidney donors

Time Frame: Annually for 5 years post donation

Study Sites (15)

Loading locations...

Similar Trials